Epithelial Tumors, Malignant Clinical Trials

6 clinical trials for Epithelial Tumors, Malignant across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Evaluation of an EpCAM-Targeted Radiotracer in Epithelial Tumors — RECRUITING · NA
• Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors — RECRUITING · PHASE1
• Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors — RECRUITING · PHASE1
• Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin — WITHDRAWN · PHASE1
• NHS-IL12 for Solid Tumors — COMPLETED · PHASE1
• A Study of the Safety and Pharmacokinetics (PK) of MEHD7945A in Participants With Locally Advanced or Metastatic Epithelial Tumors — COMPLETED · PHASE1

Refine this search